Wellcome Witness Seminar on 'The Therapeutic Implications of Muscular Dystrophy Genomics'
Tuesday April 25th
With an introduction by Professor Jan Witkowski, this Witness Seminar presents an account of the therapeutic implications of muscular dystrophy genomics. The participants provide insights into the clinical and genetic characterizations of muscular dystrophy, with a particular emphasis on Duchenne muscular dystrophy, and shed light on the research coordination and the recent approaches towards the treatment of this group of devastating pathological entities.
Dr Reuben Loffman writes for The Conversation
Friday April 21st
Dr Thomas Dixon on BBC Radio 4
Tuesday April 18th